STAT1 and Alzheimer disease: Significantly, we identified an increase in Il4 and Il13 levels as well as an increase in JAK1/2, STAT1/2/3, and P-STAT3 levels, and a decrease in these after YAP inhibitor treatment in an AD mouse model.